Announcements

Will H. Van Den Heuvel, Executive Vice President of Cincinnati Financial Corp, filed a Form 4 on November 5, 2026, reporting transactions in Cincinnati Financial common stock dated November 4, 2026, on NASDAQ:CINF.

Barclays PLC filed a Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of 3,034,244 shares of Cannae Holdings Inc common stock as of September 30, 2026.

Braveheart Bio, Inc. filed a Form 8-K on November 6, 2026, disclosing that the company and Hengrui Pharma presented data from a 52-week open-label extension of a Phase 2 study of HRS/BHB-1893 in obstructive hypertrophic cardiomyopathy at the American Heart Association Scientific Sessions 2026.

Director Ashraf Wagih Lotfi filed a Form 4 with the SEC on November 6, 2026, disclosing an automatic grant of 11,100 shares of CVD Equipment Corp common stock received on November 5, 2026, under the company's Director Compensation Plan.

Capital International Investors filed an amended beneficial ownership statement with the SEC on November 5, 2026, disclosing a 10.3% stake in Aurora Innovation, Inc. (NASDAQ:AUR) as of the event date of October 30, 2026.

Great Southern Bancorp, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 6, 2026, reporting third-quarter net income of $14.009 million and total assets of $5.821 billion.

Unilever PLC officer Fabian T. Garcia filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 32,000 American Depositary Shares on the New York Stock Exchange through Fidelity Brokerage Services LLC.